NEW JERSEY ALLIANCE FOR
CLINICAL AND TRANSLATIONAL SCIENCE
NEWS, EVENTS, and DEADLINES
|
|
NJ ACTS Pilots Program Grants
Application, RFA and Webinar
|
|
The NJ ACTS Pilot Program offers one year pilot grants to foster collaborative research among faculty in three institutions: Princeton University, New Jersey Institute of Technology (NJIT) and Rutgers University. The Pilot Program intends to increase collaborative research and provide a path to sustainable, extramurally-funded independent research across the alliance.
NJ ACTS has committed $640,000 for 2022. The program is funded through the generous support of the NIH CTSA Award, the New Jersey Health Foundation (NJHF), and each of the academic partners.
There are five different categories of projects. Collaboration requirements and funding amounts vary by project type. Translational and Clinical Sciences awards are up to 100K; Methodological/Infrastructure, Propel and Valued Partnership awards are up to 50K; and a new category, Process Innovation, has awards of up to 40K.
April 19, 2022
5:00 – 6:30 pm
Pilot Grant Application Documents
|
|
Upcoming NJ ACTS and Rutgers Events |
|
Special Populations Core
2022 Seminar Series
Culturally Re-Centering Evidence-Based Treatments
Among Indigenous Communities
|
|
Katherine (Kait) Hirchak, PhD
Assistant Professor, Elson S. Floyd College of Medicine
Washington State University
Dr. Hirchak is a federally recognized descendant of the Eastern Shoshone. In this seminar, Professor Hirchak will discuss approaches to culturally adapting evidence-based treatments among Indigenous communities with a focus on contingency management and medications for opioid use disorder.
April 12, 2022
1 pm - 2 pm
|
|
Research Resources Workshop Wednesdays (R2W2)
Seminar Series
Clinical Trials Resources
|
|
 |
Reynold A. Panettieri, Jr, M.D.
Vice Chancellor for
Translational Medicine and Science
|
|
|
|
José M. Román JD, DMin
Vice President of
Research Administration, Rutgers University
|
|
|
|
April 13, 2022
4 pm - 5 pm
|
|
NJ ACTS presents
Demystifying Decentralized Clinical Trials
Interested in decentralized or minimal touch clinical trials? Learn from key stakeholders who successfully implemented decentralized studies during the COVID-19 Pandemic. Panelists will share: Best Practices; Lessons Learned; and Future Goals.
Invited Panelists:
|
|
Reynold A. Panettieir, Jr., MD
Chair, Vice Chancellor for Translational Medicine and Science; Director, RITMS; Professor of Medicine, RWJMS; Emeritus Prof. of Medicine, University of Pennsylvania
Alexander Pastuszak, MD, PhD
President, Clinical Care; Chief Clinical Officer, Vault Health Founder & CMO, Woven Health; Assistant Professor in Andrology/Male Infertility at University of Utah
Craig Lipset, MBA
Co-Chair, Decentralized Trials and Research Alliance; Adjunct Assistant Professor, MS in Clinical Research Management
|
|
Nancy Reilly, RN, MS, CCRC, CHRC
Executive Director Rutgers, The State University of New Jersey RBHS Clinical Trials Office
Daniel B. Horton, MD, MSCE
Assistant Professor of Pediatrics, RWJMS; Assistant Professor of Epidemiology, Rutgers School of Public Health
Nadina C. Jose, MD
Assistant Professor, MS Clinical Research Management; Rutgers BioPharma Educational Initiative
|
|
|
April 14, 2022
1 pm - 2:30 pm
|
|
INSPIRE: A 3-Year Postdoctoral Opportunity
The INSPIRE Postdoctoral Program at Robert Wood Johnson Medical School (RWJMS), sponsored by NIH-IRACDA (Institutional Research and Career Development Award), provides up to three years of mentored research experience in biomedical fields at RWJMS or Rutgers University (70% effort), as well as training in educational methods - including mentored teaching at a nearby Minority-Serving Institution - and career development (30% combined effort).
The INSPIRE program serves to fulfill two important goals:
- Prepare diverse university-trained Ph.D. scholars for successful careers as scientist-educators;
- Increase the participation of diverse undergrad populations in biomedical science research fields.
Rolling admissions with review of applications beginning April 15, 2022
|
|
NJACTS Biostatistics, Epidemiology, Research Design (BERD)
Training Series
|
|
Advanced Graphics in R
Kylie Getz, MS
Biostatistician for RUBIES
April 21, 2022
3pm
|
|
Interactive Visualization
with R Shiny
Jiayi Ji, MS
Biostatistician for RUBIES
May 19, 2022
3pm
|
|
|
NJ ACTS Workforce Development Core
Virtual Clinical and Translational Science Internship
Fall 2022
Undergraduate (juniors/seniors), Professional, and Graduate students: Are you looking to build your resume in Clinical and Translational Sciences?
Application Deadline - April 18, 2022 (midnight)
|
|
NJ ACTS Services
Biostatistics, Epidemiology, Research Design (BERD)
|
|
BERD was created to enhance clinical and translational research across the NJ ACTS community by providing professional, high quality study design, quantitative and qualitative (mixed methods) data analysis, survey research and data management services, development of innovative methodologies, as well as extensive group and individual training and instruction in biostatistics, epidemiology, and research design.
CLICK HERE for Rutgers University Biostatistics & Epidemiology Services (RUBIES) support
|
|
NJ ACTS and Rutgers in the News |
|
The New Jersey Kids Study
The NJ Kids Study was created to answer: why asthma is so common in kids in New Jersey; why NJ has such high rates of autism and why obesity and related complications are increasing in incidence in children and occurring at younger ages.
Rutgers researchers believe important answers to these questions will come from studies of the human microbiome in young children. To advance the science and better understand the impact of the early microbiome on health and disease, they will perform a longitudinal study with serial assessment of the microbiome from gestation through childhood. New Jersey is an ideal setting for this work given the high density and diversity of its population, documented disparities in income as well as maternal and child health outcomes, and a unique exposome that can impact the microbiome.
Executive Committee: Gloria Bachmann, M.D.; Emily Barrett, Ph.D.; Martin J. Blaser, M.D.; Maria Gloria Dominguez Bello, Ph.D., Daniel Horton, M.D.; Reynold Panettieri Jr., M.D., Nancy Reilly RN
|
|
NJ ACTS Congratulates
Pamela Rothpletz-Puglia, PhD
This article is a result of research funded by a NJ ACTS Partnership and Innovation Accelerator Pilot (PIAP) Program Grant.
|
|
NJ ACTS Congratulates Sally Radovick, MD |
|
TRANSFORM is the Irving Institute's educational resource, administering the interdisciplinary master's, predoctoral, postdoctoral, and career development programs, which includes the KL2 program, TL1 program, and Translational Endeavors (i.e. Workforce Development resource).
Dr. Radovick serves as the NJ ACTS Core Lead for the KL2 Scholars
|
|
NJ ACTS Joins NIH 's All of Us Research Program
Genomic Dataset of Nearly 100,000 Genome Sequences
Nearly 100,000 highly diverse whole genome sequences are now available through the National Institutes of Health's All of Us Research Program. About 50% of the data is from individuals who identify with racial or ethnic groups that have historically been underrepresented in research. This data will enable researchers to address yet unanswerable questions about health and disease, leading to new breakthroughs and advancing discoveries to reduce persistent health disparities.
The genomic data is available via a cloud-based platform, the All of Us Researcher Workbench and also includes genotyping arrays from 165,000 participants.
The program will partner with one million or more people across the United States to build the most diverse biomedical data resource of its kind, to help researchers gain better insights into the biological, environmental, and behavioral factors that influence health. For more information, visit:
|
|
MS in Clinical Research Management
New Academic Research Track
|
|
Expand your Knowledge in Clinical Research Management
The Rutgers School of Health Professions is inviting all students interested in learning more about how to conduct clinical research at an Academic Medical Center.
Now accepting applications for Fall 2022!
This new track is a 16-month program designed for students with no clinical research or pharmaceutical experience but are interested in functioning as a “study coordinator”.
|
|
Upcoming CTSA and Other Events |
|
The NCATS/NIH Genomics Information Commons Un-Meeting on
Enabling and Promoting Inter-Institutional Clinical and Genomic Research
April 13, 2022
The Genomics Information Commons (GIC) invites the community to a NCATS-sponsored Un-Meeting on “Enabling and Promoting Inter-Institutional Clinical and Genomic Research.” The goal of the meeting is to solicit innovative and collaborative ideas from across the CTSA Consortium to evaluate acceptability and scalability of the GIC’s prototype system, and to ideate around next steps and future directions. Specific topics include: using and analyzing federated genome and phenome data; aligning consenting processes across the Consortium; GIC research topic opportunities – low hanging fruit; facilitation of inter-institutional research collaboration; and GIC cloud-hosted data and analytic environments and technologies for local institutional research.
The Genomic Information Commons (GIC) is an NCATS/NIH funded continuously updating, queryable, federated system enabling and promoting clinical and genomic research across eight pediatric hospitals. The GIC has established highly scalable technologies, policies, and procedures for sharing genomic data, phenotypic data, and biospecimen metadata on broadly consented cohorts, across sites of care.
|
|
CTSA Visiting Scholar Program |
|
Glands, Genes, and Surgery: Updates on Adrenal Tumor Management
Heather Wachtel, MD, MS
University of Pennsylvania
April 20, 2022
8:30 am - 9:30 am
___________________________________
Molecular Profiling for Transthyretin Cardiac Amyloidosis
Kevin Alexander, MD, FACC, FHFSA
Stanford University
April 28, 2022
11:00 am - 12:30 pm
___________________________________
A Novel Nascent Protein-Degradation-Based Mechanism
for Fast Homeostatic Plasticity
Haiyan He, Ph.D.
Georgetown University
April 29, 2022
12:00 pm - 1:00 pm
|
|
Introduction to the Multiphase Optimization Strategy (MOST) Online Course - This course is aimed at intervention scientists working in any area--including public health, education, criminal justice, and others—interested in learning about an innovative framework for conducting intervention research. Read More and Register Here!
|
|
On the Pandemic Podcast - Journalism in the Time of COVID - Host: Mary Marchetta O'Dowd, MPH, Executive Director, Health Systems and Population Health Integration, RBHS and Guest: Lindy Washburn, Health Care Reporter, The Bergen Record, NorthJersey.com, and USA Today Network - New Jersey.
|
|
Build a Successful Collaboration with NJ ACTS Team Science - The Team Science Core offers general and project-specific consultations on building and maintaining successful research teams and collaborations. To set up a consultation, please fill out the intake form. Read more about the Team Science Core.
|
|
Regulatory Knowledge and Support Core Staff Cafés - Do you need help regarding any facet of human subjects protection, FDA requirements or other regulatory issues? Join the Regulatory Knowledge and Support Core Staff at our cafés. Next Cafe is April 18, 2022,
|
|
2022 Regeneron Science to Medicine Forum - A regional biomedical conference to encourage cross-fertilization and interaction between graduate students and postdoctoral fellows doing great science across the New York Metro Area. June 16, 2022, 9 am - 5 pm, View Flyer
|
|
NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
|
|
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UL1TR003017 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
UL1TR003017, KL2TR003018 and TL1TR003019
|
|
|
|
|
|
|
|
|
|
